Neurizon Therapeutics Ltd
NUZ
Company Profile
Business description
Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).
Contact
385 Bourke Street
Suite 2, Level 11
MelbourneVIC3205
AUST: +61 396927222
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2026
Employees
52
Stocks News & Analysis
stocks
Apple: Gemini partnership lets AI-worried investors breathe a sigh of relief
We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,184.20 | 27.30 | -0.30% |
| CAC 40 | 8,314.10 | 16.86 | -0.20% |
| DAX 40 | 25,304.82 | 18.58 | 0.07% |
| Dow JONES (US) | 49,361.90 | 212.27 | 0.43% |
| FTSE 100 | 10,244.12 | 59.77 | 0.59% |
| HKSE | 26,923.62 | 76.19 | -0.28% |
| NASDAQ | 23,636.93 | 165.18 | 0.70% |
| Nikkei 225 | 54,110.50 | 230.73 | -0.42% |
| NZX 50 Index | 13,659.79 | 97.92 | -0.71% |
| S&P 500 | 6,960.98 | 34.38 | 0.50% |
| S&P/ASX 200 | 8,861.70 | 19.30 | -0.22% |
| SSE Composite Index | 4,112.60 | 13.49 | -0.33% |